This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gomez, D. Articles by Riou, J.-F. Search for Related Content PubMed PubMed Citation Articles by Gomez, D. Articles by Riou, J.-F.

The G-quadruplex Ligand Telomestatin Inhibits POT1 Binding to Telomeric Sequences In vitro and Induces GFP-POT1 Dissociation from Telomeres in Human Cells

¹ Laboratoire d'Onco-Pharmacologie, JE 2428; ² Centre National de la Recherche Scientifique UMR 6142; ³ Institut Fédératif de Recherche 53, Université de Reims Champagne-Ardenne; ⁴ Institut Jean-Godinot, Reims, France; ⁵ Laboratoire de Biologie Moléculaire de la Cellule, Centre National de la Recherche Scientifique UMR 5161, Ecole Normale Supérieure de Lyon, Lyon, France; and ⁶ Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan

Requests for reprints: Jean-François Riou, Laboratoire d'Onco-Pharmacologie, JE 2428, UFR de Pharmacie, Université de Reims Champagne-Ardenne, 51 rue Cognacq-Jay, 51096 Reims, France. Phone: 33-3-26-91-80-13; Fax: 33-3-26-91-89-26; E-mail: jf.riou{at}univ-reims.fr.

Telomestatin is a potent G-quadruplex ligand that specifically interacts with the 3' telomeric overhang, leading to its degradation and that induces a delayed senescence and apoptosis of cancer cells. Protection of Telomere 1 (POT1) was recently identified as a specific single-stranded telomere-binding protein involved in telomere capping and T-loop maintenance. We showed here that a telomestatin treatment inhibits POT1 binding to the telomeric overhang in vitro. The treatment of human EcR293 cells by telomestatin induces a dramatic and rapid delocalization of POT1 from its normal telomere sites but does not affect the telomere localization of the double-stranded telomere-binding protein TRF2. Thus, we propose that G-quadruplex stabilization at telomeric G-overhang inactivates POT1 telomeric function, generating a telomere dysfunction in which chromosome ends are no longer properly protected. (Cancer Res 2006; 66(14): 6908-12)

This article has been cited by other articles:

				A. Ghosh, M. L. Rossi, J. Aulds, D. Croteau, and V. A. Bohr Telomeric D-loops Containing 8-Oxo-2'-deoxyguanosine Are Preferred Substrates for Werner and Bloom Syndrome Helicases and Are Bound by POT1 J. Biol. Chem., November 6, 2009; 284(45): 31074 - 31084. [Abstract] [Full Text] [PDF]

				I. M. Pedroso, W. Hayward, and T. M. Fletcher The effect of the TRF2 N-terminal and TRFH regions on telomeric G-quadruplex structures Nucleic Acids Res., April 1, 2009; 37(5): 1541 - 1554. [Abstract] [Full Text] [PDF]

				Y. Wu, K. Shin-ya, and R. M. Brosh Jr. FANCJ Helicase Defective in Fanconia Anemia and Breast Cancer Unwinds G-Quadruplex DNA To Defend Genomic Stability Mol. Cell. Biol., June 15, 2008; 28(12): 4116 - 4128. [Abstract] [Full Text] [PDF]

				J. Tang, Z.-y. Kan, Y. Yao, Q. Wang, Y.-h. Hao, and Z. Tan G-quadruplex preferentially forms at the very 3' end of vertebrate telomeric DNA Nucleic Acids Res., March 27, 2008; 36(4): 1200 - 1208. [Abstract] [Full Text] [PDF]

				R. Machado-Pinilla, I. Sanchez-Perez, J. Ramon Murguia, L. Sastre, and R. Perona A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells Blood, March 1, 2008; 111(5): 2606 - 2614. [Abstract] [Full Text] [PDF]

				S. G. Hershman, Q. Chen, J. Y. Lee, M. L. Kozak, P. Yue, L.-S. Wang, and F. B. Johnson Genomic distribution and functional analyses of potential G-quadruplex-forming sequences in Saccharomyces cerevisiae Nucleic Acids Res., January 17, 2008; 36(1): 144 - 156. [Abstract] [Full Text] [PDF]

				A. T. Phan, V. Kuryavyi, K. N. Luu, and D. J. Patel Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution Nucleic Acids Res., October 8, 2007; 35(19): 6517 - 6525. [Abstract] [Full Text] [PDF]

				B. Brassart, D. Gomez, A. D. Cian, R. Paterski, A. Montagnac, K.-H. Qui, N. Temime-Smaali, C. Trentesaux, J.-L. Mergny, F. Gueritte, et al. A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells Mol. Pharmacol., September 1, 2007; 72(3): 631 - 640. [Abstract] [Full Text] [PDF]

				L. Kelland Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway Clin. Cancer Res., September 1, 2007; 13(17): 4960 - 4963. [Abstract] [Full Text] [PDF]

				Y.-C. Tsai, H. Qi, and L. F. Liu Protection of DNA Ends by Telomeric 3' G-Tail Sequences J. Biol. Chem., June 29, 2007; 282(26): 18786 - 18792. [Abstract] [Full Text] [PDF]

				C. M. Barbieri, A. R. Srinivasan, S. G. Rzuczek, J. E. Rice, E. J. LaVoie, and D. S. Pilch Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA Nucleic Acids Res., May 11, 2007; 35(10): 3272 - 3286. [Abstract] [Full Text] [PDF]

				D. Gomez, T. Wenner, B. Brassart, C. Douarre, M.-F. O'Donohue, V. El Khoury, K. Shin-ya, H. Morjani, C. Trentesaux, and J.-F. Riou Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells J. Biol. Chem., December 15, 2006; 281(50): 38721 - 38729. [Abstract] [Full Text] [PDF]